Pharmadeep Announces New Facility for Microcrystalline Cellulose Production
Pharmadeep recently announced plans to establish a new manufacturing facility focused on producing Microcrystalline Cellulose (MCC), a widely used excipient for direct compression in pharmaceutical formulations. This marks the company’s fifth project in the active pharmaceutical ingredients (API) segment. The project, which the company describes as a “state-of-the-art” facility, is in the initial curing stages, […]